Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Gyan

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
Annals of Hematology|November 16, 2013
Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years' experience in a single centreSinziana Radesi-Sarghi, Flavie Arbion, Caroline Dartigeas, et al.
Journal of Medical Case Reports|July 25, 2021
Cerebral localization of chronic myelomonocytic leukemia: a case reportClémence Haméon, Cécilia Rousselot, Flavie Arbion, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot studyDavid Ternant, Hélène Monjanel, Yann Venel, et al.
Therapie|July 10, 2016
[Not Available]Hélène Blasco, Stéphanie Silly, Jean-François Tournamille, et al.
Blood|July 5, 2003
Rituximab therapy for HIV-associated Castleman diseaseAnne-Geneviève Marcelin, Laurent Aaron, Christine Mateus, et al.
Retinal Cases & Brief Reports|January 16, 2016
A CASE OF CHORIORETINOPATHY AS FIRST MANIFESTATION OF HODGKIN'S LYMPHOMAHélène Doyen, Hélène Monjanel, Sandra Regina, et al.
Journal of Microbiological Methods|September 7, 2014
Prospective assessment of FilmArray® technology for the rapid identification of yeast isolated from blood culturesGuillaume Desoubeaux, Claire Franck-Martel, Éric Bailly, et al.
Therapie|April 5, 2008
[The need for a better definition of therapeutic indications of carboxypeptidase in delayed elimination of methotrexate]Hélène Blasco, Stéphanie Silly, Jean-François Tournamille, et al.
Haematologica|March 7, 2024
Health-related quality of life in patients with hematologic malignancies treated with chimeric antigen receptor T-cell therapy: review and current progressEmmanuelle Tchernonog, Aline Moignet, Amélie Anota, et al.
Leukemia & Lymphoma|February 16, 2013
Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patientsHervé Ghesquières, Aspasia Stamatoullas, Olivier Casasnovas, et al.
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Annals of Hematology|November 16, 2013
Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years' experience in a single centreSinziana Radesi-Sarghi, Flavie Arbion, Caroline Dartigeas, et al.
Journal of Medical Case Reports|July 25, 2021
Cerebral localization of chronic myelomonocytic leukemia: a case reportClémence Haméon, Cécilia Rousselot, Flavie Arbion, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot studyDavid Ternant, Hélène Monjanel, Yann Venel, et al.
Therapie|July 10, 2016
[Not Available]Hélène Blasco, Stéphanie Silly, Jean-François Tournamille, et al.
Blood|July 5, 2003
Rituximab therapy for HIV-associated Castleman diseaseAnne-Geneviève Marcelin, Laurent Aaron, Christine Mateus, et al.
Retinal Cases & Brief Reports|January 16, 2016
A CASE OF CHORIORETINOPATHY AS FIRST MANIFESTATION OF HODGKIN'S LYMPHOMAHélène Doyen, Hélène Monjanel, Sandra Regina, et al.
Journal of Microbiological Methods|September 7, 2014
Prospective assessment of FilmArray® technology for the rapid identification of yeast isolated from blood culturesGuillaume Desoubeaux, Claire Franck-Martel, Éric Bailly, et al.
Therapie|April 5, 2008
[The need for a better definition of therapeutic indications of carboxypeptidase in delayed elimination of methotrexate]Hélène Blasco, Stéphanie Silly, Jean-François Tournamille, et al.
Haematologica|March 7, 2024
Health-related quality of life in patients with hematologic malignancies treated with chimeric antigen receptor T-cell therapy: review and current progressEmmanuelle Tchernonog, Aline Moignet, Amélie Anota, et al.
Leukemia & Lymphoma|February 16, 2013
Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patientsHervé Ghesquières, Aspasia Stamatoullas, Olivier Casasnovas, et al.
Pageof 18